Jazz Pharmaceuticals PLC Equity-NMS: JAZZ

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$113.33

Open :

$113.1

Today's high :

$115.8

Today's low :

$112.49

52W low :

$95.49

52W high :

$148.06

EPS(TTM): :

-6.98

Shares O/S :

60.66 M

Market cap :

6.98 B

What is the share price of Jazz Pharmaceuticals PLC today?

Jazz Pharmaceuticals PLC (JAZZ) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Jazz Pharmaceuticals PLC?

Yes, Indian Investors can invest in the Jazz Pharmaceuticals PLC (JAZZ) Share by opening an international trading account with Angel One.

How can I purchase Jazz Pharmaceuticals PLC shares in India?

Purchasing Jazz Pharmaceuticals PLC (JAZZ) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Jazz Pharmaceuticals PLC (JAZZ) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Jazz Pharmaceuticals PLC?

Yes, you can purchase fractional shares of Jazz Pharmaceuticals PLC (JAZZ) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Jazz Pharmaceuticals PLC?

The market capitalization of Jazz Pharmaceuticals PLC on January 1, 1970, is $0.

What documents are required to invest in Jazz Pharmaceuticals PLC stocks?

In order to invest in Jazz Pharmaceuticals PLC (JAZZ) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Jazz Pharmaceuticals plc is a global biopharmaceutical company. It is engaged in developing medicines for people with serious diseases, often with limited or no therapeutic options. It has a diverse portfolio of marketed medicines, including therapies for sleep disorders and epilepsy, and a portfolio of cancer treatments. Its lead-marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Ziihera (zanidatamab-hrii), and Enrylaze (recombinant crisantaspase). Its product candidates include Zanidatamab, Vyxeos, JZP815, JZP898, JZP441, and others. Xywav is used for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy. The Company, through Chimerix, Inc., also owns a clinical asset, dordaviprone, a novel small molecule treatment in development for H3 K27M-mutant diffuse glioma.